SeaStar Medical Holding (ICU) Accumulated Expenses (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Accumulated Expenses came in at $2.9 million in Q1 2026, down 11.0% YoY from $3.3 million in Q1 2025, and up 27.73% on a QoQ basis from $2.3 million in Q4 2025.
SeaStar Medical Holding (ICU) Accumulated Expenses (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Accumulated Expenses data on file, last reported at $2.9 million in Q1 2026.
- Quarterly Accumulated Expenses fell 11.0% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 11.0% YoY) and the FY2025 annual result came in at $2.3 million, down 28.86% from the prior year.
- Accumulated Expenses advanced to $2.9 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $3.3 million in Q1 2025 to a low of $309465.0 in Q1 2022.
- A 5-year average of $1.7 million and a median of $1.7 million in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 7056.91% — and 2024, when it tumbled 62.56%.
- Tracing ICU's Accumulated Expenses over 5 years: stood at $2.2 million in 2022, then sank by 32.16% to $1.5 million in 2023, then surged by 109.32% to $3.2 million in 2024, then slipped by 28.86% to $2.3 million in 2025, then grew by 27.73% to $2.9 million in 2026.
- The last three Accumulated Expenses figures came in at $2.9 million (Q1 2026), $2.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.47 Mn |
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 625,000.00 |
| Mar 31, 2025 | 3.26 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Jun 30, 2024 | 856,000.00 |
| Mar 31, 2024 | 671,000.00 |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 309,465.00 |
| Dec 31, 2021 | 58,000.00 |
| Sep 30, 2021 | 277,306.00 |
| Jun 30, 2021 | 49,321.00 |
| Mar 31, 2021 | 4,324.00 |